Cargando…
Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scores
BACKGROUND: Generalized pairwise comparisons (GPC) can be used to assess the net benefit of new treatments for rare diseases. We show the potential of GPC through simulations based on data from a natural history study in mucopolysaccharidosis type IIIA (MPS IIIA). METHODS: Using data from a historic...
Autores principales: | Deltuvaite-Thomas, Vaiva, De Backer, Mickaël, Parker, Samantha, Deneux, Marie, Polgreen, Lynda E., O’Neill, Cara, Salvaggio, Samuel, Buyse, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571482/ https://www.ncbi.nlm.nih.gov/pubmed/37828533 http://dx.doi.org/10.1186/s13023-023-02943-8 |
Ejemplares similares
-
Trial Design for Cancer Immunotherapy: A Methodological Toolkit
por: Saad, Everardo D., et al.
Publicado: (2023) -
The uncertainty related to the inexactitude of prioritization based on consistent pairwise comparisons
por: Kazibudzki, Pawel Tadeusz
Publicado: (2023) -
A fast and powerful W-test for pairwise epistasis testing
por: Wang, Maggie Haitian, et al.
Publicado: (2016) -
A fast and powerful W-test for pairwise epistasis testing
por: Wang, Maggie Haitian, et al.
Publicado: (2016) -
Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer
por: Péron, J, et al.
Publicado: (2015)